These results imply that although differing cells have various response mechanisms to melatonin, the induced transcription of Nestin, Bmi-1 and Sox2 by melatonin is able to initiate a molecular proliferative response in C6 glioma cells that may contribute to the observed level of resistance to melatonin. The gene discussed is NES; the disease is glioma.